This program is designed specifically for businesses like yours that are engaged in cancer research. It offers funding to advance research into cancer causes and early detection methods. You will access high-quality biospecimens from the NCI’s PLCO Screening Trial, which includes valuable data on demographics, lifestyle, and screening results. This could be a pivotal moment for your research, leading to groundbreaking discoveries that have the potential to save lives.

By applying, you gain the opportunity to explore a variety of research avenues without the burden of immediate repayment. This funding allows you to focus on enhancing your research efforts and making meaningful contributions to cancer science. Additionally, with no limitations on revenue or employee counts, this program is accessible to any business, large or small, enabling you to seize the resources you need to innovate and grow.

Why apply? Here are the key benefits for you:

• Access unique biorepository resources.
• Investigate groundbreaking cancer-related research.
• Advance your work with financial support you won’t need to repay.

This is a chance to not only elevate your business but also to play a role in transformative cancer research.

This program offers grant funding specifically for research projects. Grants do not require repayment, which means they provide you with funds that can be used to advance your research without the worry of debt.

Repayment Terms and Interest Rates

There are no repayment terms or interest rates with this grant. This means you can focus completely on your research without the added pressure of paying back any funds.

Eligible Expenses

The eligible expenses under this program include costs associated with using the PLCO biospecimens for research, such as:

• Laboratory analyses related to cancer etiology
• Data collection and analysis expenses
• Costs for personnel involved in the research project

Ineligible Expenses

Funds cannot be used for expenses unrelated to the research project or for projects that do not involve the use of PLCO biospecimens.

Fees Associated

There are no fees associated with applying or receiving grant funding from this program. You receive the full amount awarded without hidden costs.

• Business Location: Available across the country.
• Sectors: Open to all sectors.
• Employees: No minimum or maximum number of employees required.
• Company Revenue: No minimum or maximum revenue qualifications.
• Legal Structure: All legal structures are applicable.
• Profit Structure: All profit structures are applicable.

Disqualifications:

• Research projects must involve the use of PLCO biospecimens; projects not using PLCO biospecimens will not be supported.

This program offers funding for research into the causes of cancer and early detection methods. By utilizing the unique resources from the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial, your business can access high-quality biospecimens. These include pre-diagnostic blood samples and data on demographics, lifestyle choices, and screening results.

You can use this funding to explore a variety of research avenues, such as analyzing cancer risk factors or developing new early detection biomarkers. This could lead to groundbreaking discoveries that can enhance cancer research and potentially save lives.

The funds are available to businesses of all sizes and legal structures, with no minimum or maximum requirements for revenue or employees. This is an excellent chance to elevate your research efforts without the burden of immediate repayment. You can focus on advancing your work while contributing to significant advancements in cancer research.